Document 215961
Download
Report
Transcript Document 215961
John Rother
Director
Policy & Strategy
Medicare
Rx Drug Coverage: The Need
Today’s pharmaceuticals do far more than
mitigate symptoms:
Control chronic conditions
Protect against acute episodes
Reverse course of disease, in some cases
And, significantly improve the quality of life
For Medicare-eligible
What are people’s Rx drug costs?
$0
<$1K
10%
25%
$1-3K $3-5K
30%
16%
$5-8K
$8-10K
$10K+
11%
3%
5%
CBO Projected 2006
Distribution of typical costs
over approximately 40 million
beneficiaries
Impact of New Law in 2006
$12,000
TOTAL Rx SPENDING
$10,000
$8,000
Medicare pays
Person's Co-pay
Person's Premiums
$6,155
$6,000
$1,500
$4,000
$1,500
$2,000
$1,313
$188
$563
$0
$500
$1,000
$2,000
$3,000
Prescription cost
$5,000 $10,000
The Standard Benefit Design
95%
75%
…
$250
$2250
Total Rx
Spending
$3600 out-of-pocket
Rx Spending
FINAL
As passed
$35 monthly premium
($420 per year)
Referred to as the DONUT HOLE
13.4 Million Low-Income
Medicare Beneficiaries Helped
Below 135% FPL
Assets Below $6,000**
• No Premium
• No Premium
• No Deductible
• No Coverage
Gap
• $1 Copay for
Generic
• $3 Copay for
Brand-name
• No Copay if in
nursing home
• No Copay over
the $3,600 limit*
• No Deductible
• No Coverage
Gap
• $2 Copay for
Generic
• $5 Copay for
Brand-name
4.4 million
• No Copay over
the $3,600 limit*
6.9 million
Below 135% FPL
Assets Below $10,000**
135% & 150% FPL
Assets Below $10,000
• No Premium
• Sliding Scale
Premium
• $50 Deductible
• $50 Deductible
• No Coverage
• No Coverage
Gap
Gap
• 15% Coinsurance • 15% Coinsurance
• $2 Generic or $5
Brand-name
Copay over the
$3,600 limit*
• $2 Generic or $5
Brand-name
Copay over the
$3600 limit*
0.7 million
1.4 million
2003 CBO Estimate
Dual Eligibles
Below 100% FPL
Other Low-Income Protections
Immediate help
Offers a Medicare discount card as a
“transition” benefit for low-income
without other Rx coverage -- adds $600/yr
Begins in June, 2004
and ends January, 2006
Choices in Benefit Design
Private benefit designs will differ
even though based on same
actuarial value as Medicare Rx
2 or more private insurance plans or
federal fallback using the
‘standard benefit’
Enrollment
• Voluntary, can choose either:
– Stand-alone plans sponsored by PBMs
– PPO/HMO plans (Medicare Advantage)
– No plan, pay no premium
• Annual open-season
• Late sign-up penalties = 1% per
month, or as HHS Sec determines
Medicare Structural Changes
Strengthens Medicare
Adds chronic care
management
Adds new prevention benefits
Requires electronic prescribing
for doctors and pharmacies,
which will improve quality
Protects Covered Retirees
Employer-provided retiree health coverage
Allocates $71b in direct subsidies
–now tax free – for employers
who offer retirees Rx drug
coverage equivalent to Medicare
Sec. 631 was dropped (permitted
employers to provide retiree
health coverage only until age 65)
Effect on Employers
Typical employer: Expected to
retain benefits for present &
near-retirees -- limit for future
Large employers most likely to
“wrap-around” Medicare Rx,
AARP surveys in 2002 indicated
Unfinished Agenda
Initiatives to keep
pharmaceutical costs down
Initiatives to
strengthen benefits
Unfinished Agenda
Cost initiatives
Give HHS Sec negotiating power
Legalize importation
Call industry to limit price rises
Fund “effectiveness” research
Speed generic approval
Require plans disclosure prices
Reform direct-to-consumer ads
Reform detailing practices –AMA
Unfinished Agenda
Benefit design initiatives
Close the donut hole
Eliminate asset tests
Change indexing to CPI-U
Improve coordination with State
Rx aid
Strengthen ‘fallback’ provisions
Allow States to be Rx plans